The current price of ATNM is $1.43 — it has increased by 10.00% since the previous close. Data as of Nov 6, 2026.
ATNM is down 3.38% over the past week, up 33.64% over the past month and up 13.49% over the past year. The price is above its 200-day moving average of $1.12.
Analysts' average 12-month price target for ATNM is $11.07, which implies 674.13% upside from the current price. Individual estimates range from $4.00 to $24.26.
Of the 3 analysts covering Actinium Pharmaceuticals, Inc., 1 rates it a strong buy and 2 rate it a buy. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Actinium Pharmaceuticals, Inc. has a market capitalization of $44.96M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Actinium Pharmaceuticals, Inc. posted earnings of $0.89 per share against an estimate of -$0.20, beating expectations by 545.00%. Upcoming reports are listed in the earnings calendar.
Actinium Pharmaceuticals, Inc. reported revenue of $35M in its most recent quarter. Analysts had expected $35M.
Actinium Pharmaceuticals, Inc. has not paid any dividends over the past year.
Companies most comparable to Actinium Pharmaceuticals, Inc. include OnKure Therapeutics, Inc., PDS Biotechnology Corporation, Xilio Therapeutics, Inc., Kezar Life Sciences, Inc. and LAVA Therapeutics N.V.
In the latest trading session ATNM moved between $1.28 and $1.43, a range of 10.49% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Actinium Pharmaceuticals, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Actinium Pharmaceuticals, Inc. is neutral. Technical ratings are indicators, not investment advice.
Over the past 52 weeks ATNM has traded between $0.7351 and $1.72. The current price is 16.86% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.